1
e-TRANZACT INTERNATIONAL PLC (eTRANZACT)
Quarter Under Preview: 9-Months 2025
Current Share Price: N17.35
Price At Released: N12.70
Latest Final Dividend: N0.0125
Latest Interim Dividend:
Estimated Beta Value: 0.59x
Estimated Intrinsic Value: N4.82
Rating: Watch
Analyst: Jeariogbe Tunde Segun
The Company
e-Tranzact International Plc is a pioneering Nigerian financial technology company established in September 2003
to provide electronic payment solutions.
It is recognised as one of Africa’s premier electronic transaction switching and payment processing platforms, serving as a critical infrastructure provider for banks, businesses, and government institutions.
Founded in 2003 as a private limited liability company with an initial capital of N1,000,000, the firm quickly evolved from a simple pay outlet for services like Econet Wireless (now Airtel) and the Lagos State Water Corporation into a comprehensive, multi-channel payment solution. In 2009, e-Tranzact became a publicly listed company on the Nigerian Stock Exchange.
The company operates as an integrated payment processor with services spanning mobile banking, card payments,
Automated Teller Machines (ATM), Point of Sale (POS), and web-based transactions.
The Released Numbers
At the end of the nine months financial year of e-Tranzact, the management reported a Turnover figure of N20.114 billion, this is 8.26% below the N21.924billion reported at the end of the corresponding quarter in 2024. Direct Cost of Sales for the period is estimated at N10.208 billion versus N14.528 billion in the corresponding quarter.
Operating Profit at the end of the period was estimated at N3.141 billion compared to N2.892 billion in the comparable period. Operating Expenses was valued at N6.763 billion from N2.892 billion in 2024.
Thus, Profit before Tax stood at N3.438 billion from N3.058 billion in the same quarter of last year. After considering the Tax Expenses, the total Profit for the quarter was estimated at N2.407 billion versus N2.140 billion of last quarter. See the below table for details
Also, at the end of the quarter under review, the Current Assets of the company was valued at N21.328 billion, slightly above the N21.034 billon of the previous quarter. Non-Current Assets valuation stood at N4.106 billion against N2.485 billion.
Thus, Total Assets valuation is N25.435 billion as against N23.520 billion in the corresponding quarter. On the other hand, Current Liability estimate was N9.093 billion against N9.618 billion, Non-Current Liability stood at N212.982 million against N283.254 million, thereby putting the Total Liabilities figure at N9.306 billion versus N9.901 billion.
Net Assets is now N16.128 billion from N13.618 billon. Re tained Earnings is positive N4.153 billion versus N1.643 billion. See the above table for details.
Financial Strength Ratios
- Debt Ratio: As shown in the below table, the Debt Ratio of etranzact is currently 36.59% against 42.10%.
- This means that only 36.59% of Etranzact’s assets are financed by debt, down significantly from the prior year ratio. The decline signals reduced leverage and lower financial risk. Please observe that, for a Fintech/Payment company, this is positive because it improves resilience against revenue volatility and regulatory shocks.
- Total Debt to Equity Ratio: The Ratio moved from 72.71% to the current 57.71%. This indicates that debt relative to shareholders’ funds has dropped sharply. A sub-60% ratio suggests the company is not aggressively leveraged and is increasingly funded by owners rather than lenders.
- Equity Ratio: Is currently 63.41% Vs 57.90%. This means that, equity now funds over 63% of Total Assets, please observe that this is a strong position.
The rising equity ratio aligns with the falling debt metrics and shows capital strengthening. This gives Etranzact more shock-absorbing capacity during downturns.
Overall Verdict for Financial Ratios: The Company is moving towards a more conservative, stable, and sustainable capital structure, which is especially positive for a fintech operating in a regulated and competitive environment like Nigeria.
Profitability Ratio
- EBITDA Margin: 15.62% Vs 13.19%: Operating profitability has improved meaningfully, and this suggests better cost control, stronger pricing, or improved transaction mix. For a payment/fintech company, rising EBITDA margin often reflects scale benefits and operational discipline.
This also suggests that core operations are more efficient, earnings quality is improving, and operating leverage is positive.
- Pre-Tax Margin: 17.10% Vs 13.95%. Profit before Tax has grown faster than revenue. This indicates lower finance costs, and improved non-operating performance.
The jump reinforces that profitability gains are not just operational but bottom line driven. We can therefore interpret this further as; stronger earnings conversion, reduced drag from interest and overheads, and healthier income statement.
- Cost of Sales to Turnover: 50.75% Vs 66.27%: This is a dramatic reduction in cost of sales relative to revenue. This is one of the strongest signals in the numbers of etranzact. It implies better vendor terms, improved platform efficiency, or higher margin products.
- Return on Equity (ROE): 14.37% Vs 15.72%: Despite stronger margins, ROE dipped marginally, this is likely equity base (retained earnings), which dilutes ROE even when profits rise. Importantly, this decline is not operational weakness, but a balance sheet effect.
- Return on Assets (ROA): 9.46% Vs 9.10%: Assets base has improved, and this means that Etranzact is extracting more profit from each naira of assets. This rise aligns well with improved cost structure and margins.
Overall Verdicts of Profitability Ratios: Profitability is structurally improving, driven by cost efficiency and operating leverage, while the mild ROE drop reflects a healthier, less leveraged balance sheet, not weakening performance.
Efficiency Ratio
- Operating Expenses to Turnover Ratio: 33.63% Vs 20.545. Operating expenses are now consuming a much larger portion of revenue.
- This suggests cost creep in areas like staff cost, IT Infrastructures, marketing, compliance and others. While margins improved earlier, this jump indicates that profitability gains are being partially offset by rising overheads.
This can be interpreted as; weak operating cost discipline, expansion or restructuring cost are likely.
- Turnover to Total Assets: 79.08% Vs 93.21%. Asset turnover has declined, meaning assets are generating less revenue than before, this may reflect; new assets not yet fully productive, idle cash balances, or investment in platforms or systems awaiting scale.
Overall Verdict of Efficiency Ratio: eTranzacrt appears to be in an investment or expansion phase. While this pressures efficiency ratios now, the earlier margin improvements suggest the core business remains sound.
The key question going forward is whether revenue growth will catchup with the higher cost and asset base.
Investment Ratios
1.Earnings Per Share(EPS): N0.26 Vs N0.23. The EPS growth confirms that profits attributable to shareholders increased. This aligns with the improved margins and ROA seen earlier.
Please understand that growth is modest but positive and real, not dilution-driven. This shows improving shareholders’ earnings, quality growth signals and still low absolute EPS level.
- Pe-Ratio: 48.54x Vs 32.23x. The stock is now trading at a much higher multiple. This reflects either of the followings; rising share price faster than earnings, or strong market optimism about future growth, especially since the company recently exited negative retained earnings position. For a company with weakening efficiency, this valuation looks stretched.
- Earnings Yield: 2.05% Vs 3.10%. Falling earnings yield is the inverse effect of the rising P/E. At just 2.05%, returns are well below risk-free alternatives. This weakens the stock’s appeal for income-oriented or value investors
- Book Value per Share: N1.75 Vs N5.07. This shows growth in shareholders equity per share, not erosion.
The increase suggests retained earnings accumulation and balance sheet strengthening. This aligns with rising equity ratio, improved ROA and reduced leverage.
Final Verdict for Investment Ratio: We can conclude that Etranzact is taking the right step operationally, but the stock price already reflects a lot of optimsm. Best suited for patient growth investors, not bargain hunters- unless earnings growth accelerates meaningfully in coming quarters.
Overall Verdict: We can conclude that etranzact numbers as improving but not yet optimal. etranzact delivered a solid operational recovery in Q3 2025, and this is marked by;
- Stronger balance sheet (lower leverage, higher equity funding)
- Clear margin expansion, driven mainly by lower cost of sales
- Improving asset profitability
However, this was partially offset by; rising operating expenses, weaker asset turnover, and a valuation that now runs ahead of fundamentals. This company appears to be in a transition/investment phase-doing the right strategic things, but still paying short term efficiency costs.
The bottom line is a company improving in the right direction, but the market has already noticed this. Future upside now depends on revenue catching up with the higher cost and asset base.
Read the full article here
